Barakat Muna, Nassar Razan, Gharaibeh Lobna, Thiab Samar, Nashwan Abdulqadir J
Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Pharmacological and Diagnostic Research Center, Biopharmaceutics and Clinical Pharmacy Department, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Med Princ Pract. 2024;33(6):505-518. doi: 10.1159/000541009. Epub 2024 Aug 19.
This review explores the current landscape and future directions of deprescribing and polypharmacy practices in Jordan. The prevalence of polypharmacy, defined as the concurrent use of multiple medications by an individual, has been increasing in recent years due to various factors, such as population aging and the greater availability of medications. However, polypharmacy can lead to adverse drug events, suboptimal medication adherence, increased healthcare costs, and reduced quality of life. Deprescribing, on the other hand, involves the discontinuation or reduction of unnecessary or potentially harmful medications to improve patient outcomes. The findings presented in this review highlight the current state of deprescribing and polypharmacy practices in Jordan, including factors influencing their prevalence. Additionally, it discusses the challenges healthcare professionals face in implementing deprescribing strategies and identifies potential solutions for enhancing these practices in Jordanian healthcare settings. Moreover, this paper provides insights into future directions for deprescribing and polypharmacy practices in Jordan. Overall, this review offers valuable insights into the current landscape of deprescribing and polypharmacy practices in Jordan while also providing recommendations for future directions to optimize medication management strategies that can ultimately benefit patient outcomes within a sound healthcare system framework.
本综述探讨了约旦减药和多重用药实践的现状及未来方向。多重用药的定义是个体同时使用多种药物，近年来由于人口老龄化和药物可及性提高等多种因素，其患病率一直在上升。然而，多重用药可能导致药物不良事件、用药依从性欠佳、医疗成本增加以及生活质量下降。另一方面，减药涉及停用或减少不必要或有潜在危害的药物，以改善患者预后。本综述呈现的研究结果突出了约旦减药和多重用药实践的现状，包括影响其患病率的因素。此外，它还讨论了医疗保健专业人员在实施减药策略时面临的挑战，并确定了在约旦医疗环境中加强这些实践的潜在解决方案。此外，本文还提供了约旦减药和多重用药实践未来方向的见解。总体而言，本综述为约旦减药和多重用药实践的现状提供了宝贵见解，同时也为未来方向提供了建议，以优化药物管理策略，最终在健全的医疗系统框架内使患者受益。
